苏州旺山旺水生物医药股份有限公司（旺山旺水-B，股票代码：02630）于2026年6月4日公布2026年5月（截至5月31日）股份变动月报表。根据公告，报告期内，公司已发行股份总数、注册股本及库存股份数量均保持不变。
公告显示，截至5月31日，旺山旺水-B所发行的H股数为66,677,133股，面值均为人民币1元；非上市股份为100,920,667股，面值同为人民币1元。两类股份在5月均无增加或减少。至报告期末，公司法定/注册股本总额合计为人民币167,597,800元。
报告期内，公司未发生新的股份发行、购回、注销或库存股变动，也无任何股份期权、权证或可换股票据的发放、行使或终止情况。公司同时确认相关事项均符合香港联合交易所有限公司《上市规则》及其他适用法律法规的要求。
据公告披露，本次月报由董事会秘书兼联席公司秘书郭婷签署。公司表示，将持续关注资本运作及公司治理，确保符合监管规定。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.